Financhill
Back

NBT Bancorp Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
34

NBTB
NBT Bancorp

Last Price:
$45.20
Seasonality Move:
-1.87%
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
34
NBT Bancorp (NBTB) is a Sell

Is NBT Bancorp a Buy, Sell or Hold?

  • The current NBT Bancorp [NBTB] share price is $46.38. The Score for NBTB is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NBTB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NBTB Stock Price Chart

What is NBT Bancorp's stock price today?

  • The NBT Bancorp share price today is $46.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBTB is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $48.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

NBTB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 35.22 Sell
Chaikin Money Flow: -22875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.62 - 50.84) Sell
Bollinger Bands (100): (44.5 - 49.68) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -235099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.1 - 56.94) Sell
Bollinger Bands (100): (51.5 - 57.46) Sell

NBTB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.46 Sell
20-day SMA: 49.1 Sell
50-day SMA: 48.82 Sell
200-day SMA: 42.9 Buy
8-day EMA: 47.46 Sell
20-day EMA: 48.39 Sell
50-day EMA: 48.28 Sell
200-day EMA: 44.14 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.85 Sell
20-day SMA: 53.18 Sell
50-day SMA: 55.63 Sell
200-day SMA: 51.03 Sell
8-day EMA: 50.82 Sell
20-day EMA: 52.67 Sell
50-day EMA: 54.22 Sell
200-day EMA: 49.96 Sell

NBT Bancorp Earnings Growth & NBTB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.79 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

NBT Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):